Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jun 17.
Published in final edited form as: Org Lett. 2011 May 26;13(12):3222–3225. doi: 10.1021/ol2011242

Acetoxy Meldrum’s Acid: A Versatile Acyl Anion Equivalent in the Pd-Catalyzed Asymmetric Allylic Alkylation

Barry M Trost 1,*, Maksim Osipov 1, Philip S J Kaib 1, Mark T Sorum 1
PMCID: PMC3144701  NIHMSID: NIHMS299905  PMID: 21615099

Abstract

graphic file with name nihms299905u1.jpg

Acetoxy Meldrum’s acid can serve as a versatile acyl anion equivalent in the Pd-catalyzed asymmetric allylic alkylation. The reaction of this nucleophile with various meso and racemic electrophiles afforded alkylated products in high yields and enantiopurities. These enantioenriched products are versatile intermediates that can be further functionalized using nitrogen– and oxygen–centered nucleophiles, affording versatile scaffolds for the synthesis of nucleoside analogues. These scaffolds were used to complete formal syntheses of the anti-HIV drugs carbovir, abacavir, and the antibiotic aristeromycin.


The high therapeutic value of nucleoside analogues in the treatment of viral infections including hepatitis, the herpes virus, and HIV is unquestionable.1 Nucleoside analogues inhibit viral replication by acting as non-specific chain terminators during DNA transcription. However, the high propensity for resistance caused by viral mutation necessitates the development of new nucleoside analogues.2 Current methods for the synthesis of furanose nucleoside analogues rely on carbohydrate precursors, which are only available as the D-enantiomer from natural sources.3 The use of highly oxygenated carbohydrate starting materials also requires the extensive use of protecting groups which reduces synthetic efficiency (Figure 1). Carbanucleosides, which contain a methylene group in place of the furanose oxygen, are synthesized using chiral pool strategies and enzymatic resolution, limiting access to both enantiomers.4

Figure 1.

Figure 1

Strategies to access nucleoside analogues

Recently, L-nucleosides have gained increased attention for their potent antiviral activity. These compounds frequently display lower toxicity, and higher activity due to their greater metabolic stability compared to D-nucleosides.5 Hence, the development of methods that provide ready access to both enantiomers of nucleoside analogues is desirable.

By in large, nucleoside analogues contain a hydroxymethylene side chain on the “sugar” moiety. This functionality can be installed through the reaction of an aldehyde with a nucleophile.3b,6 However, installation of a hydroxymethylene unit in an umpolung manner, using an acyl anion equivalent, remains a difficult transformation. Acyl anion equivalents provide a method to construct C–C bonds by reversing the inherent electrophilic reactivity of a carbonyl group.7 While dithianes8 as well as other acyl anions, have been studied extensively in this capacity, their asymmetric introduction, remains a challenge.9

The Pd-catalyzed asymmetric allylic alkylation (Pd-AAA) is a powerful method for the stereoselective construction of C–C and C–X bonds.10 In the past, the Pd-AAA has been used to construct nucleosides and their analogues by employing purine and pyrimidine nucleophiles.11 However, use of an acyl anion equivalent in the Pd-AAA to access nucleoside analogues as well as other chiral scaffolds containing this functionality remains under studied. We imagined that acetoxy Meldrum’s acid (1) could serve as a good nucleophile and a general acyl anion equivalent in such processes under mildly basic conditions.12 Simple hydrolysis of the acetonide functionality followed by oxidative decarboxylation with ceric ammonium nitrate (CAN) should unmask the carboxylic acid functionality (Figure 1).13 This carboxylic acid handle could be reduced to the corresponding aldehyde or hydroxymethylene as needed. Inspired by the significance of nucleoside analogues, we envisioned that the use of acetoxy Meldrum’s acid as an acyl anion equivalent, and its application to the Pd-AAA would provide an enabling method for the rapid assembly of both enantiomers of carbocyclic and heterocyclic nucleoside analogues (Figure 1).

We began our studies by investigating the reaction of meso dicarbonate 2a with acetoxy Meldrum’s acid (1) (Table 1, entry 1). Treatment of this system with 2.5 mol % Pd2(dba)3•CHCl3 and (R,R)-L1 in 1,2–dichloroethane (DCE) with Cs2CO3 as a base afforded the alkylated product 3a in 91% yield and 99% ee. Reaction of the 5-membered dicarbonate14 2b under the same reaction employing (R,R)-L2 as ligand conditions provided the alkylated product 3b in 97% yield and 98% ee (entry 2). Likewise, the meso dihydrofuran15 2c reacted smoothly to generate the alkylated dihydrofuran 3c in 90% yield and 92% ee (entry 3). The success of the five-membered ring meso electrophiles is noteworthy due to their utility as building blocks in the synthesis of both carbocyclic and heterocyclic nucleoside analogues, respectively (vide infra). Additionally, 3b and 3c were easily prepared on gram–scale without deterioration of yields or enantiopurities. Reaction of the tropone-derived meso dicarbonate 2d provided the substituted product 3d in 78% yield and 90% ee (entry 4). Both carbonate and ester-leaving groups could be utilized in this transformation to afford the desired products in high yields and enantiopurities.

Table 1.

Scope of Electrophiles in the Pd-AAA with Acetoxy Meldrum’s Acid (1)a

graphic file with name nihms299905u2.jpg
entry electrophile product % yieldb % eec
1 graphic file with name nihms299905t1.jpg
2a
graphic file with name nihms299905t2.jpg
3a
99 99
2 graphic file with name nihms299905t3.jpg
2b
graphic file with name nihms299905t4.jpg
3b
97d 98
3 graphic file with name nihms299905t5.jpg
2c
graphic file with name nihms299905t6.jpg
3c
90d 92
4 graphic file with name nihms299905t7.jpg
2d
graphic file with name nihms299905t8.jpg
3d
78 90
5 graphic file with name nihms299905t9.jpg
rac2e
graphic file with name nihms299905t10.jpg
3e
91 99
6 graphic file with name nihms299905t11.jpg
rac2f
graphic file with name nihms299905t12.jpg
3f
99 99
7 graphic file with name nihms299905t13.jpg
2g
graphic file with name nihms299905t14.jpg
3g
75 99

graphic file with name nihms299905t15.jpg graphic file with name nihms299905t16.jpg
a

All reactions were performed with 1.0 equiv 1, 1.0 equiv of electrophile 2 and 1.1 equiv of Cs2CO3, 0.25M in DCE at ambient temperature.

b

Isolated yield.

c

%ee was determined by chiral HPLC.

d

(R,R)-L2 was used.

With conditions developed for meso electrophiles, we turned our attention to racemic substrates. Treatment of racemic cyclohexenyl benzoate rac2e with acetoxy Meldrum’s acid (1) under conditions used for meso electrophiles provided the alkylated product 3e in 91% yield and 99% ee (entry 5). Incorporating substitution on the cyclohexene ring had little effect on the transformation and rac2f was alkylated to 3f in 81% yield and 99% ee (entry 6). Likewise, C2 symmetric tetracarbonate 2g was examined in the transformation, and provided the product 3g in 75% yield and 99% ee (entry 7). In all cases examined, the alkylation product was obtained exclusively as a single regio– and diastereo isomer.

To provide a wide range of functionalized scaffolds for the synthesis of nucleoside analogues, the products 3b and 3c were alkylated a second time using a diastereoselective Pd-catalyzed allylic substitution. In this reaction, the use of enantiopure ligands was not necessary, since the chiral center established in the initial Pd-AAA would dictate the diastereoselectivity of the second alkylation. Both 3b and 3c were selected for their abilities to serve as scaffolds for a large number of nucleoside analogues. Both nitrogen– (Table 2, entries 1–6) and oxygen–centered (entry 7) nucleophiles were successfully utilized and afforded the substituted products (5a–g) in high yields as a single diastereomer. Both pyrrole 4a and phthalimide 4b underwent substitution with chiral cyclopentene 3b in near-quantitative yields to afford cyclopentenes 5a and 5b (entries 1 and 2). Substitution of dihydrofuran 3c with 6-chloropurine (4c) to afford 5c (entry 3) is important, as it provides an appropriately functionalized intermediate for the synthesis of several purine-derived nucleoside analogues through manipulation of the dihydrofuran olefin and purine side chain. Reaction of cyclopentene 3b with triazole 4d provided 5d (entry 4) in 74% yield, which contains the carbon skeleton of several biologically active analogues of the broad-spectrum antiviral agent ribavirin.16 Coupling of dihydrofuran 3c with 2-hydroxypyrimidine•HCl (4f) provided 5f (entry 6), which contains the carbon skeleton for the DNA methylation inhibitor zebularine.17

Table 2.

Pd-Catalyzed Allylic Substitutionsa

graphic file with name nihms299905u3.jpg
entry electrophile nucleophile product % yieldb
1 3b graphic file with name nihms299905t17.jpg
4a
graphic file with name nihms299905t18.jpg
5a
99
2 3b graphic file with name nihms299905t19.jpg
4b
graphic file with name nihms299905t20.jpg
5b
97
3 3c graphic file with name nihms299905t21.jpg
4c
graphic file with name nihms299905t22.jpg
5c
83c
4 3b graphic file with name nihms299905t23.jpg
4d
graphic file with name nihms299905t24.jpg
5d
74
5 3b TMSN3
4e
graphic file with name nihms299905t25.jpg
5e
99d
6 3c graphic file with name nihms299905t26.jpg
4f
graphic file with name nihms299905t27.jpg
5f
81e
7 3b graphic file with name nihms299905t28.jpg
4g
graphic file with name nihms299905t29.jpg
5g
81

graphic file with name nihms299905t30.jpg
a

All reactions were performed with 1.0 equiv 3, 1.0 equiv of 4 and 1.1 equiv of Cs2CO3 0.25M in DCE at ambient temperature.

b

Isolated yield.

c

Performed using 5 mol % Pd2(dba)3•CHCl3, 15 mol % (±)-L1, 10 mol % Bu3SnOAc with 3.0 equiv NEt3 in THF.

d

Performed in THF in the absence of base.

e

Performed using 5 mol % Pd2(dba)3•CHCl3, 15 mol % (±)-L1, with 3.0 equiv NEt3 in THF.

Pd-catalyzed substitution of cyclopentene 3b with TMSN3 (4e) generated allyl azide 5e in 99% yield (entry 5). This compound was used to complete the formal syntheses of several biologically active nucleoside analogues (Scheme 1). Basic hydrolysis of allyl azide 5e with LiOH followed by oxidative decarboxylation with CAN and methylation of the liberated carboxylic acid with TMSCHN2 provided ester 6 in 67% yield over 3 steps. Reduction of the ester and azide functionalities with LiAlH4 yielded the corresponding amino alcohol that was acylated directly with acetic anhydride to afford acetylated amino alcohol 7 in 91% over two steps. Acetylated amino alcohol 7 is a known intermediate in the synthesis of the HIV drugs carbovir,18 abacavir,19 and the antibiotic aristeromycin.20

Scheme 1.

Scheme 1

Formal Syntheses of Carbovir, Abacavir, and Aristeromycin

In conclusion, we have developed acetoxy Meldrum’s acid (1) as a versatile nucleophile and acyl anion equivalent in the Pd-AAA. Both meso and racemic electrophiles reacted with acetoxy Meldrum’s acid (1) to provide the desired alkylated products in high yields and enantiopurities in a chemo-, regio-, and diastereoselective fashion. The products from the Pd-AAA were then subjected to second Pd-catalyzed allylic substitution using both nitrogen– and oxygen–centered nucleophiles. Formal syntheses of carbovir, abacavir, and aristeromycin were completed to demonstrate an application of this method in short syntheses of carbanucleoside analogues.

Supplementary Material

1_si_001

Acknowledgments

We thank the National Science Foundation and the National Institutes of Health (GM33049) for their generous support of our programs. M.O. thanks the John Stauffer Memorial Fellowship for financial support. Palladium salts were generously supplied by Johnson-Matthey.

Footnotes

Supporting Information Available Experimental details and spectral data for all unknown compounds. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.(a) Huryn DM, Okabe M. Chem Rev. 1992;92:1745. [Google Scholar]; (b) Simons C. Nucleoside Mimetics: Their Chemistry and Biological Properties. Gordon and Breach Science Publishers; Amsterdam: 2001. [Google Scholar]
  • 2.Kiertiburanakul S, Sungkanuparph S. Curr HIV Res. 2009;7:273. doi: 10.2174/157016209788347976. [DOI] [PubMed] [Google Scholar]
  • 3.(a) Ferrero M, Gotor V. Chem Rev. 2000;100:4319. doi: 10.1021/cr000446y. [DOI] [PubMed] [Google Scholar]; (b) Vorbrüggen H, Ruh-Pohlenz C. Handbook of Nucleoside Synthesis. John Wiley & Sons; New York: 2001. [Google Scholar]
  • 4.(a) Crimmins MT. Tetrahedron. 1998;54:9229. [Google Scholar]; (b) Afonso CAM, Kurteva VB. Chem Rev. 2000;109:6809. doi: 10.1021/cr900169j. [DOI] [PubMed] [Google Scholar]; (c) Schneller SW. Curr Top Med Chem. 2002;2:1087. doi: 10.2174/1568026023393228. [DOI] [PubMed] [Google Scholar]
  • 5.(a) Jahnke TS, Nair V. Antimicrob Agents Chemother. 1995;39:1017. doi: 10.1128/aac.39.5.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Gosselin G, Mathé C. Antiviral Res. 2006;71:276. doi: 10.1016/j.antiviral.2006.04.017. [DOI] [PubMed] [Google Scholar]
  • 6.(a) Lee W, Kim K-H, Surman MD, Miller MJ. J Org Chem. 2003;68:139. doi: 10.1021/jo026488z. [DOI] [PubMed] [Google Scholar]; (b) Cesario C, Miller MJ. Org Lett. 2009:11–1293. doi: 10.1021/ol9000685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Seebach D. Angew Chem Int Ed Engl. 1979;18:239. [Google Scholar]
  • 8.Smith AB, III, Adams CM. Acc Chem Res. 2004;37:365. doi: 10.1021/ar030245r. [DOI] [PubMed] [Google Scholar]
  • 9.(a) Aggarwal VK, Esquivel-Zamora BN. J Org Chem. 2002;67:8618. doi: 10.1021/jo026410i. [DOI] [PubMed] [Google Scholar]; (b) Seemann M, Schöller M, Kudis S, Helmchen G. Eur J Org Chem. 2003:2122. [Google Scholar]; (c) Johnson JS. Curr Opin Drug Disc Dev. 2007;10:691. [PubMed] [Google Scholar]; (d) Hashimoto T, Hirose M, Maruoka K. J Am Chem Soc. 2008;130:7556. doi: 10.1021/ja802704j. [DOI] [PubMed] [Google Scholar]; (e) Förster S, Tverskoy O, Helmchen G. Synlett. 2008:2803. [Google Scholar]
  • 10.(a) Trost BM, Van Vranken DL. Chem Rev. 1996;96:395. doi: 10.1021/cr9409804. [DOI] [PubMed] [Google Scholar]; (b) Trost BM, Crawley ML. Chem Rev. 2003;103:2921. doi: 10.1021/cr020027w. [DOI] [PubMed] [Google Scholar]; (c) Trost BM. J Org Chem. 2004;69:5813. doi: 10.1021/jo0491004. [DOI] [PubMed] [Google Scholar]; (d) Trost BM, Machacek MR, Aponick A. Acc Chem Res. 2006;39:747. doi: 10.1021/ar040063c. [DOI] [PubMed] [Google Scholar]; (e) Trost BM, Fandrick DR. Aldrichim Acta. 2007;40:59. [Google Scholar]
  • 11.(a) Trost BM, Li L, Guile SD. J Am Chem Soc. 1992;114:8745. [Google Scholar]; (b) Trost BM, Shi Z. J Am Chem Soc. 1996;118:3037. [Google Scholar]; (c) Trost BM, Kallander LS. J Org Chem. 1999;64:5427. doi: 10.1021/jo990195x. [DOI] [PubMed] [Google Scholar]; (d) Trost BM, Madsen R, Guile SD, Brown B. J Am Chem Soc. 2000;122:5947. [Google Scholar]
  • 12.Schank K, Blattner R. Chem Ber. 1981;114:1958. [Google Scholar]
  • 13.Salomon MF, Pardo SN, Salomon RG. J Am Chem Soc. 1984;106:3797. [Google Scholar]
  • 14.Kaneko C, Sugimoto A, Tanaka S. Synthesis. 1974:876. [Google Scholar]
  • 15.Elming N, Claason-Kaas N. Acta Chem Scand. 1952;6:535. [Google Scholar]
  • 16.Noble SN, Beddall NE, Beveridge AJ, Marr CLP, Mo CL, Myers PL, Penn CR, Storer R, Woods JM. Nucleosides and Nucleotides. 1991;10:487. [Google Scholar]
  • 17.Yoo CB, Cheng JC, Jones PA. Biochem Soc Trans. 2004;32:910. doi: 10.1042/BST0320910. [DOI] [PubMed] [Google Scholar]
  • 18.Vince R, Hua M. J Med Chem. 1990;33:17. doi: 10.1021/jm00163a004. [DOI] [PubMed] [Google Scholar]
  • 19.Daluge SM, Martin MT, Sickles BR, Livingston DA. Nucleosides, Nucleotides & Nucleic Acids. 2000;19:297. doi: 10.1080/15257770008033011. [DOI] [PubMed] [Google Scholar]
  • 20.Csuk R, Dörr P. Tetrahedron. 1995;51:5789. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES